European Journal of Pediatrics

, Volume 178, Issue 1, pp 81–87 | Cite as

Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants

  • Dan Zhou
  • Fang Shi
  • Ying Xiong
  • Min Zhou
  • Huajing WanEmail author
  • Hanmin LiuEmail author
Original Article


Bronchopulmonary dysplasia (BPD) is one of the most common chronic inflammatory lung disease of premature infants, with serious short- and long-term consequences. Early identification of premature infants at risk of BPD is critical to preventing the pathogenesis of disease. Thus, in the present study, we recruited 126 premature infants, collected peripheral blood samples at different time points during early life, and measured the concentration of Th1 (MCP-1, IP-10, and MIG) and Th2 (eotaxin-1, eotaxin-2, and MCP-4) chemokines in serum. We found serum eotaxin-2 levels were significantly higher in the BPD group than in the non-BPD group on day 1 [1662 pg/ml vs. 1221 pg/ml, P < 0.05], day 7 [1533 pg/ml vs. 1089 pg/ml, P < 0.05], and day 14 [1246 pg/ml vs. 704 pg/ml, P < 0.05] after birth, and serum MCP-4 levels were also significantly higher in the BPD group than in the non-BPD group on day 1 [186 pg/ml vs. 128 pg/ml, P < 0.05], day 7 [199 pg/ml vs. 101 pg/ml, P < 0.05], and day 14 [238 pg/ml vs. 106 pg/ml, P < 0.05] of life.

Conclusions: Increased levels of Th2 chemokines, eotaxin-2, and MCP-4, are associated with BPD in premature infants.

What is Known:

The pathogenesis of BPD is multifactorial and it is difficult to predict and prevent.

Previous studies have demonstrated that inflammation plays a major role in the pathogenesis of BPD.

What is New:

Increased Th2 chemokines, eotaxin-2 and MCP-4, were associated with BPD in premature infants.

Abnormal Th1/Th2 response in early life maybe associated with the subsequent development of BPD, which provide a new insight to understand the pathogenesis of the disease.


Biomarker Bronchopulmonary dysplasia Inflammation Premature infants Th1/Th2 chemokines 



bronchopulmonary dysplasia


extremely low birth weight


interferon (IFN) gamma-induced protein


monocyte chemotactic protein


monokine induced by interferon-γ


T helper type



The authors thank the study participants and their parents. In addition, the authors gratefully acknowledge the support from the National Key R&D Program of China (No. 2017YFC0211705) and the National Natural Science Foundation of China (No. 81601326).

Authors’ contributions

Participated in research design: Hanmin Liu, Huajing Wan, and Dan Zhou.

Conducted experiments: Dan Zhou and Fang Shi.

Performed data analysis: Fang Shi, Ying Xiong, and Min Zhou.

Wrote or contributed to the writing of the manuscript: Dan Zhou, Fang Shi, and Hanmin Liu.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants’ parents included in the study.


  1. 1.
    Ambalavanan N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD (2009) Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123(4):1132–1141CrossRefGoogle Scholar
  2. 2.
    Balany J, Bhandari V (2015) Understanding the impact of infection, inflammation, and their persistence in the pathogennesis of bronchopulmonary dysplasia. Front Med 2:90CrossRefGoogle Scholar
  3. 3.
    Bonecchi R, Graham GJ (2016) Atypical chemokine receptors and their roles in the resolution of the inflammatory response. Front Immunol 7:224CrossRefGoogle Scholar
  4. 4.
    Brostrom EB, Katz-Salamon M, Lundahl J, Hallden G, Winbladh B (2007) Eosinophil activation in preterm infants with lung disease. Acta Paediatr 96(1):23–28CrossRefGoogle Scholar
  5. 5.
    Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F (2014) T helper cells plasticity in inflammation. Cytometry A 85(1):36–42CrossRefGoogle Scholar
  6. 6.
    Frezza S, Gallini F, Palazzo R, Carollo M, De Carolis MP, D’Andrea V, Catenazzi P, Romagnoli C, Ausiello CM (2016) T-cell polarization: potential serological markers in preterm and term infants. Early Hum Dev 101:69–71CrossRefGoogle Scholar
  7. 7.
    Hodge DL, Reynolds D, Cerban FM, Correa SG, Baez NS, Young HA, Rodriguez-Galan MC (2012) MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes. Eur J Immunol 42(10):2644–2654CrossRefGoogle Scholar
  8. 8.
    Islam JY, Keller RL, Aschner JL, Hartert TV, Moore PE (2015) Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med 192(2):134–156CrossRefGoogle Scholar
  9. 9.
    Jimenez-Alvarez L, Zuniga J, Gaxiola M, Checa M, Becerril C, Mendoza F, Pardo A, Selman M (2010) Inflammatory response and dynamics of lung T cell subsets in Th1, Th2 biased and Th2 deficient mice during the development of hypersensitivity pneumonitis. Exp Mol Pathol 88(3):407–415CrossRefGoogle Scholar
  10. 10.
    Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–1729CrossRefGoogle Scholar
  11. 11.
    Koksal N, Kayik B, Cetinkaya M, Özkan H, Budak F, Kiliç Ş, Canitez Y, Oral B (2012) Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. Eur Cytokine Netw 23(2):29–35Google Scholar
  12. 12.
    Manicone AM, Burkhart KM, Lu B, Clark JG (2008) CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res 34(7):391–407CrossRefGoogle Scholar
  13. 13.
    Meyer-Hoffert U, Lezcano-Meza D, Bartels J, Montes-Vizuet AR, Schröder JM, Teran LM (2003) Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells. Int Arch Allergy Immunol 131(4):264–271CrossRefGoogle Scholar
  14. 14.
    Odaka M, Matsukura S, Kuga H et al (2007) Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin_CCL-11 expression in human airway smooth muscle cells. Int Arch Allergy Immunol 143(1):84–88CrossRefGoogle Scholar
  15. 15.
    Raphael I, Nalawade S, Eagar TN, Forsthuber TG (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74(1):5–17CrossRefGoogle Scholar
  16. 16.
    Rojas-Ramos E, Avalos AF, Perez-Fernandez L, Cuevas-Schacht F, Valencia-Maqueda E, Teran LM (2003) Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma. Eur Respir J 22(2):310–316CrossRefGoogle Scholar
  17. 17.
    Ryan RM, Ahmed Q, Lakshminrusimha S (2008) Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol 34(2):174–190CrossRefGoogle Scholar
  18. 18.
    Schneibel KR, Fitzpatrick AM, Ping XD, Brown LA, Gauthier TW (2013) Inflammatory mediator patterns in tracheal aspirate and their association with bronchopulmonary dysplasia in very low birth weight neonates. J Perinatol 33(5):383–387CrossRefGoogle Scholar
  19. 19.
    Shahzad T, Radajewski S, Chao CM, Bellusci S, Ehrhardt H (2016) Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr 3(1):23CrossRefGoogle Scholar
  20. 20.
    Speer CP (2009) Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 95(4):353–361CrossRefGoogle Scholar
  21. 21.
    Stocks J, Hislop A, Sonnappa S (2013) Early lung development: lifelong effect on respiratory health and disease. Lancet Respir Med 1(9):728–742CrossRefGoogle Scholar
  22. 22.
    Stoll BJ, Hansen NI, Bell EF et al (2010) Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126(3):443–456CrossRefGoogle Scholar
  23. 23.
    White JR, Lee JM, Dede K et al (2000) Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-1, eotaxin-2, and monocyte chemotactic protein-4-induced eosinophil migration. J Biol Chem 275(47):36626–36631CrossRefGoogle Scholar
  24. 24.
    Yang JY, Cha J, Shim SY, Cho SJ, Park EA (2014) The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks’ gestation. Korean J Pediatr 57(4):171–177CrossRefGoogle Scholar
  25. 25.
    Zhang B, Ohtsuka Y, Fujii T, Baba H, Okada K, Shoji H, Nagata S, Shimizu T, Yamashiro Y (2005) Immunological development of preterm infants in early infancy. Clin Exp Immunol 140(1):92–96CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.The Vascular Remodeling and Developmental Defects Research Unit, West China Institute of Women and Children’s Health, West China Second University HospitalSichuan UniversityChengduChina
  2. 2.Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University HospitalSichuan UniversityChengduChina
  3. 3.Maternal Child Information Office, Chengdu Shuangliu District Maternal and Child Health HospitalChengduChina
  4. 4.Chengdu Newgenegle Biotech Co. Ltd.ChengduChina
  5. 5.Department of Pediatric Pneumology, West China Second University HospitalSichuan UniversityChengduChina

Personalised recommendations